Epiglue

Delhi, India
Medical device for closure of skin wounds using tissue adhesive.

About Epiglue

Epiglue is a Healthcare company based in Delhi (India). Medical device for closure of skin wounds using tissue adhesive. The company has 1 employees. Its Indian entity Epiglue Pharma Private Limited reported revenue of β‚Ή79.8 Lakh. Epiglue offers products and services including Epiglue Tissue Adhesive and Wound Closure Solutions. Its focus areas include Surgical Supplies, Adhesives, Tissue Bonding and Medical Devices.

Company details

Epiglue is a cyanoacrylate-based tissue adhesive that is utilized for the closure of topical skin cuts and wounds with approximated edges. It is stored at room temperature and applied via a patented micro delivery system, which ensures high purity and minimal infection risk. The product is intended for external use by medical professionals and is not suitable for internal applications or contaminated sites. Contraindications include areas of high moisture and patients with allergies to cyanoacrylate. Certifications such as ISO 13485 and ISO 9001 are held, reflecting adherence to quality standards, while testimonials note its role in promoting fast healing and ease of use.

  • Headquarters Delhi, India
  • Employees 1
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social Instagram YouTube
  • Legal Name Epiglue Pharma Pvt. Ltd
  • Date of Incorporation 22 Oct, 2021
  • Jurisdiction Nsp, Delhi, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹79.8 Lakh

    FY 2024 · +186% YoY

  • Net Profit
    ₹3.7 Lakh

    FY 2024 · 5% margin

  • EBITDA
    ₹5.6 Lakh

    FY 2024 · 7% margin

  • Employee Count
    1

Products & Services of Epiglue

Epiglue offers a comprehensive portfolio of products and services, including Epiglue Tissue Adhesive and Wound Closure Solutions.

Epiglue Tissue Adhesive
Medical Devices

A cyanoacrylate adhesive that is utilized for closing topical skin wounds and incisions with minimal tension

Wound Closure Solutions
Healthcare Services

Solutions that are provided for the management of skin cuts and incisions through adhesive applications

Apps and channels of Epiglue

its YouTube channel Epiglue has 0026 subscribers.

Epiglue
YouTube 0026 subscribers
Open channel

Board of directors of Epiglue Pharma Private Limited (Epiglue)

Epiglue Pharma Private Limited is the primary company behind Epiglue. The board of Epiglue Pharma Private Limited currently have 2 directors; the longest-serving is Swadha Saraogi, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Swadha Saraogi
DIN 06770396
Director22 Oct 20215 yrsEpiglue Pharma Private Limited
Hemant Saraogi
DIN 01536658
Director22 Oct 20215 yrsEpiglue Pharma Private Limited

Financials of Epiglue

Figures of Epiglue Pharma Private Limited, the primary company behind Epiglue, for FY 2024. Revenue was ₹79.8 Lakh (+186% year on year). Net profit was ₹3.7 Lakh (5% margin). EBITDA was ₹5.6 Lakh (7% margin).

  • ₹79.8 LakhRevenue · FY 2024 · +186% YoY
  • ₹3.7 LakhNet profit · 5% margin
  • ₹5.6 LakhEBITDA · 7% margin
  • ₹1.3 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Epiglue Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Epiglue

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Epiglue

Epiglue is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Epiglue has 1 employees.

The primary company behind Epiglue, Epiglue Pharma Private Limited, reported revenue of β‚Ή79.8 Lakh for FY 2024, up 186% year on year.

Epiglue is a cyanoacrylate-based tissue adhesive that is utilized for the closure of topical skin cuts and wounds with approximated edges. It is stored at room temperature and applied via a patented micro delivery system, which ensures high purity and minimal infection risk. The product is intended for external use by medical professionals and is not suitable for internal applications or contaminated sites. Contraindications include areas of high moisture and patients with allergies to cyanoacrylate. Certifications such as ISO 13485 and ISO 9001 are held, reflecting adherence to quality standards, while testimonials note its role in promoting fast healing and ease of use.

Epiglue offers Epiglue Tissue Adhesive and Wound Closure Solutions.

Epiglue operates through Epiglue Pharma Private Limited.

The legal entities of Epiglue currently have 2 directors, including Swadha Saraogi, Hemant Saraogi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available